Home›Stock Screener›Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Share Price Today | Stock Price & Dr. Agarwal's Health Care Share Screener

AGARWALEYE Healthcare Services
Live Share Price NSE
₹553.10
▲ 3.60 (0.66%)
2026-11-19 00:00:00
Live Share Price BSE
₹554.90
▲ 5.55 (1.01%)
2026-11-19 00:00:00

As of November 19, 2026, the live Dr. Agarwal's Health Care share price (NSE: AGARWALEYE) is ₹553.10 on NSE and ₹554.90 on BSE, up 0.66% from the previous close, with shares trading between ₹544.70 and ₹558.50 in today's trading session, and a 52-week range of ₹406.55–₹560.70. Track AGARWALEYE market cap trends to gauge the company's total market size. Use the Dr. Agarwal's Health Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Dr. Agarwal's Health Care opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹665 and net income of ₹57, with EBITDA of ₹186, an operating margin of 27.0% and a profit margin of 8.6%.

Dr. Agarwal's Health Care Market Cap ₹17,117.83 Cr.
AGARWALEYE P/E Ratio (TTM) 85.00
Dr. Agarwal's Health Care P/B Ratio 7.81
EPS (TTM) ₹4.21
Dividend Yield -
Debt to Equity 0.52
AGARWALEYE 52 Week High ₹560.70
Dr. Agarwal's Health Care 52 Week Low ₹406.55
Operating Margin 27.00%
Profit Margin 8.57%
AGARWALEYE Revenue (TTM) ₹665.00
EBITDA ₹186.00
Net Income ₹57.00
Total Assets ₹3,942.00
Total Equity ₹2,120.00

Dr. Agarwal's Health Care Share Price Chart

Track the current stock price of Dr. Agarwal's Health Care with an interactive chart. Analyse AGARWALEYE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Dr. Agarwal's Health Care stock quote in one place.

The quote of ₹553.10 sits between the 52-week low of ₹406.55 and the 52-week high of ₹560.70, and the latest session moved 0.66% from the previous close.

Dr. Agarwal's Health Care Company Profile - Fundamental Screener

Screen Dr. Agarwal's Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AGARWALEYE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE943P01029.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE943P01029

Dr. Agarwal's Health Care Balance Sheet Screener

Screen AGARWALEYE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,942, up from ₹3,672 in 2025.

Latest statistics put total assets at ₹3,942 and shareholder funds at ₹2,120, with a leverage ratio of 0.52.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 3,942 3,672 2,753 1,825 1,026 787 752
Current Assets 0 0 0 0 0 0 0
Fixed Assets 2,870 2,523 1,746 1,293 702 575 551

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 1,361 1,267 974 865 586 438 339
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 2,120 1,927 1,380 659 234 199 267
Share Capital 32 32 9 8 7 7 7
Reserves & Surplus 1,993 1,835 1,330 622 206 177 242

Dr. Agarwal's Health Care Income Statement Screener - Profit & Revenue Analysis

Screen Dr. Agarwal's Health Care income statement and profit fundamentals. Analyze AGARWALEYE quarterly results. Dr. Agarwal's Health Care reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹665 and net profit was ₹57, equal to earnings per unit of ₹1.65, at an operating margin of 27%.

In that period expenses were ₹480, interest cost ₹23 and tax ₹23. The next period listed, 2026-Jun, shows revenue of ₹620 and net profit of ₹55.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec

Revenue and Expenses

Revenue 665 620 578 540 507 501 476 443 429 410 369 345
Expenses 480 444 403 386 363 360 332 316 310 300 241 244

Operating Costs and Margins

EBITDA 186 177 175 155 144 141 144 128 119 110 128 101
Operating Profit % 27.00% 28.00% 29.00% 27.00% 27.00% 26.00% 28.00% 27.00% 26.00% 26.00% 31.00% 27.00%
Depreciation 83 78 77 69 68 63 60 58 57 56 47 43
Interest 23 23 22 21 23 25 25 28 28 27 27 22

Profit and Earnings

Profit Before Tax 80 75 77 65 54 54 59 41 33 27 54 36
Tax 23 20 27 21 17 16 16 13 12 9 13 13
Net Profit 57 55 50 44 37 38 43 28 21 18 41 23
EPS 1.65 1.55 1.25 1.07 1.07 0.95 1.04 0.73 0.45 0.43 1.39 1.94

Dr. Agarwal's Health Care Cash Flow Screener - Liquidity Fundamentals

Screen AGARWALEYE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹519, and net cash flow was an outflow of ₹10.

Over the same period, investing activities used ₹309 and financing activities used ₹220.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities 519 357 346 233 164 99 103
Investing Activities -309 -750 -914 -509 -155 -46 -85

Financing and Net Cash

Financing Activities -220 382 553 303 35 -37 -74
Net Cash Flow -10 -11 -15 27 44 17 -56

Dr. Agarwal's Health Care Shareholding Pattern Screener

See Dr. Agarwal's Health Care shareholding pattern with promoter, FII, and DII holdings. Check Dr. Agarwal's Health Care promoter holding and ownership changes for AGARWALEYE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 32.36%, foreign institutions 57.94%, domestic institutions 7.83% and the public 1.68%, spread across 43,538 shareholders.

The shareholder count was 43,538 in 2026-Mar, compared with 42,492 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Jan 2025-Feb 2025-Mar 2025-Jun 2025-Sept

Promoter Holding

Promoter Holding 32.36% 32.34% 32.33% 37.73% 32.45% 32.45% 32.42% 32.42%

Institutional Investors

FII Holding 57.94% 57.96% 49.56% 0.00% 56.97% 60.62% 59.26% 58.13%
DII Holding 7.83% 7.72% 15.87% 0.00% 5.10% 5.21% 6.44% 7.92%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 1.68% 1.81% 1.82% 0.00% 4.79% 1.61% 1.74% 1.41%
Other Holding 0.19% 0.17% 0.41% 62.27% 0.69% 0.11% 0.14% 0.11%
Shareholder Count 43,538 42,492 42,055 43 217,289 68,696 63,021 48,168

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Dr. Agarwal's Health Care. Dr. Agarwal's Health Care dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Dr. Agarwal's Health Care.

Dr. Agarwal's Health Care Stock Index Membership - Nifty & Sensex

See which indices include Dr. Agarwal's Health Care stock. Check AGARWALEYE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 2 indices, including BSE INDEX BSEIPO.

Among the benchmarks tracked are BSE INDEX BSEIPO, NIFTY IPO.

Complete Index List

BSE INDEX BSEIPO
NIFTY IPO

Dr. Agarwal's Health Care Market Events Screener - Corporate Actions

Get Dr. Agarwal's Health Care corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Dr. Agarwal's Health Care stock events that may affect AGARWALEYE share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 5, 2026, with a record date of November 5, 2026.

It is followed by Annual General Meeting dated September 21, 2026 and Quarterly Result Announcement dated August 4, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-05 2026-11-05 Quarterly Result Announcement NA 11.78%
2026-09-21 2026-09-21 Annual General Meeting NA 0.63%
2026-08-04 2026-08-04 Quarterly Result Announcement NA 1.63%
2026-07-02 2026-07-02 Extraordinary General Meeting NA -3.02%
2026-05-21 2026-05-21 Quarterly Result Announcement NA 2.95%
2026-02-03 2026-02-03 Quarterly Result Announcement NA -1.33%
2025-10-30 2025-10-30 Quarterly Result Announcement NA -5.93%
2025-09-24 2025-09-24 Annual General Meeting NA 6.16%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 0.07%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -6.56%
2025-02-14 2025-02-14 Quarterly Result Announcement NA 11.55%

Dr. Agarwal's Health Care Competitors Screener - Peer Stocks Comparison

Screen AGARWALEYE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 125,272 53.90 25,420 15.58% 2,003 61.89
Max Healthcare Institute 100,339 71.20 8,536 18.82% 1,442 76.17
Manipal Health Enterprises 92,333 104.20 10,521 25.80% 917 60.80
Aster DM Quality Care 64,325 116.10 4,769 11.25% 427 57.55
Fortis Healthcare 60,910 57.00 9,179 16.93% 1,064 57.30
Narayana Hrudayalaya 38,984 45.00 7,996 43.43% 811 61.49
Global Health 38,830 62.80 4,509 19.56% 554 64.64
Dr. Lal Path Labs 33,237 57.20 2,864 12.11% 510 54.28
Krishna Institute of Medical Sciences 32,269 163.00 3,931 28.16% 242 66.73
Syngene International 17,533 95.70 3,809 2.56% 317 61.78

Dr. Agarwal's Health Care Company Announcements - News & Reports Screener

Screen AGARWALEYE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 18, 2026.

The next most recent announcements are dated November 13, 2026 and November 5, 2026.

Date Update Actions
2026-11-18 Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements -
2026-11-13 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-05 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-05 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-11-05 Corrigendum To Outcome Of The Board Meeting Held On November 05 2026 -
2026-11-05 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-11-05 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-05 Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026 -
2026-11-05 Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-10-23 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-23 Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30 2026 -
2026-10-20 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-10-20 Fixation Of Record Date W.R.T. The Scheme Of Amalgamation Between Dr. Agarwals Eye Hospital Limited And Dr. Agarwals Health Care Limited -
2026-10-20 Board Meeting Outcome for Material Update On The Scheme Of Amalgamation Between Dr. Agarwals Eye Hospital Limited And Dr. Agarwals Health Care Limited And Their Respective Shareholders And Creditors -
2026-10-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-05 Announcement under Regulation 30 (LODR)-Scheme of Arrangement -
2026-09-29 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-09-29 Announcement under Regulation 30 (LODR)-Cessation -
2026-09-28 Closure of Trading Window -
2026-09-21 Shareholder Meeting / Postal Ballot-Scrutinizers Report -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹553.10, within a 52-week range of ₹406.55 to ₹560.70. The P/E ratio is 85.00 and the P/B ratio is 7.81, with earnings per unit of ₹4.21. Market capitalisation stands at ₹17,117.83 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 7 balance sheet periods, 12 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.